Treatment Patterns, Socioeconomic Status and Clinical Burden in Mild COPD: A Swedish Real-World, Retrospective Cohort Study, the ARCTIC Study

被引:3
作者
Larsson, Kjell [1 ]
Lisspers, Karin [2 ]
Stallberg, Bjorn [2 ]
Johansson, Gunnar [2 ]
Gutzwiller, Florian S. [3 ]
Mezzi, Karen [3 ]
Bjerregaard, Bine Kjoeller [4 ]
Jorgensen, Leif [4 ]
Koo, Hyewon [5 ]
Janson, Christer [6 ]
机构
[1] Karolinska Inst, Natl Inst Environm Med, Integrat Toxicol, SE-17177 Stockholm, Sweden
[2] Uppsala Univ, Dept Publ Hlth & Caring Sci, Family Med & Prevent Med, Uppsala, Sweden
[3] Novartis Pharma AG, Basel, Switzerland
[4] IQVIA Solut, Copenhagen, Denmark
[5] IQVIA Solut, Solna, Sweden
[6] Uppsala Univ, Dept Med Sci Resp Allergy & Sleep Res, Uppsala, Sweden
关键词
chronic obstructive pulmonary disease; socioeconomic status; comorbidities; co-medications; annual income; exacerbation; Sweden; ECONOMIC OUTCOMES; PHYSICAL-ACTIVITY; DISEASE SEVERITY; IMPACT; UNDERDIAGNOSIS; COMORBIDITIES; EXACERBATION; PREVALENCE; DIAGNOSIS;
D O I
10.2147/COPD.S364932
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Patients with mild chronic obstructive pulmonary disease (COPD) account for more than half of the total COPD population but are often undiagnosed and sparsely studied. This real-world, longitudinal study compared the socioeconomic burden, clinical characteristics and treatment patterns in patients with mild COPD and age-and gender-matched controls. Patients and methods: Our population included mild COPD patients (forced expiratory volume in one second >= 80% of predicted value) and reference controls from 52 Swedish primary care centres over 15 years (2000-2014). We linked electronic medical record (EMR) data to Sweden's National Health Registries. The outcomes analyzed were socioeconomic status including annual income from work, presence of comorbidities and the use of medications. Results: 844 patients with mild COPD were included in this study and matched with 844 reference controls. Compared with the reference controls, mild COPD patients had a significantly lower annual income from work (mean difference, men: 12,559 euro and women: 7143 euro ) and were significantly less likely to be married or employed. The presence of comorbidities, including cardiovascular disease, anxiety and depression (only women) was significantly higher in mild COPD patients. The use of medications, such as proton pump inhibitors, antidepressants, central painkillers and sleep medications, was significantly higher in the mild COPD group. Conclusion: Mild COPD presents a considerable socioeconomic and clinical burden compared with reference controls The findings suggest that COPD constitutes a condition that influences health status even in mild disease clearly demanding an increased need for early detection and treatment.
引用
收藏
页码:1409 / 1421
页数:13
相关论文
共 29 条
[1]  
[Anonymous], 2017, PNEUMOLOGIE, V71, P9
[2]   What have we learned from observational studies and clinical trials of mild to moderate COPD? [J].
Barrecheguren, Miriam ;
Gonzalez, Cruz ;
Miravitlles, Marc .
RESPIRATORY RESEARCH, 2018, 19
[3]   Socioeconomic variations in chronic obstructive pulmonary disease prevalence, diagnosis, and treatment in rural Southwest China [J].
Cai, Le ;
Wang, Xu-Ming ;
Fan, Lu-Ming ;
Shen, Jing-Rong ;
Liu, Ying-Nan ;
Golden, Allison Rabkin .
BMC PUBLIC HEALTH, 2020, 20 (01)
[4]   Prevalence of comorbidities in COPD patients by disease severity in a German population [J].
Greulich, Timm ;
Weist, Benjamin J. D. ;
Koczulla, Andreas Rembert ;
Janciauskiene, Sabina ;
Klemmer, Andreas ;
Lux, Wolfram ;
Alter, Peter ;
Vogelmeier, Claus F. .
RESPIRATORY MEDICINE, 2017, 132 :132-138
[5]   Unemployment in chronic airflow obstruction around the world: results from the BOLD study [J].
Gronseth, Rune ;
Erdal, Marta ;
Tan, Wan C. ;
Obaseki, Daniel O. ;
Amaral, Andre F. S. ;
Gislason, Thorarinn ;
Juvekar, Sanjay K. ;
Koul, Parvaiz A. ;
Studnicka, Michael ;
Salvi, Sundeep ;
Burney, Peter ;
Buist, A. Sonia ;
Vollmer, William M. ;
Johannessen, Ane .
EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (03)
[6]   Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease. [J].
Hurst, John R. ;
Vestbo, Jorgen ;
Anzueto, Antonio ;
Locantore, Nicholas ;
Muellerova, Hana ;
Tal-Singer, Ruth ;
Miller, Bruce ;
Lomas, David A. ;
Agusti, Alvar ;
MacNee, William ;
Calverley, Peter ;
Rennard, Stephen ;
Wouters, Emiel F. M. ;
Wedzicha, Jadwiga A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (12) :1128-1138
[7]   Identifying the associated risks of pneumonia in COPD patients: ARCTIC an observational study [J].
Janson, Christer ;
Johansson, Gunnar ;
Stallberg, Bjorn ;
Lisspers, Karin ;
Olsson, Petter ;
Keininger, Dorothy L. ;
Uhde, Milica ;
Gutzwiller, Florian S. ;
Jorgensen, Leif ;
Larsson, Kjell .
RESPIRATORY RESEARCH, 2018, 19 :172
[8]   Primary Care COPD Patients Compared with Large Pharmaceutically-Sponsored COPD Studies: An UNLOCK Validation Study [J].
Kruis, Annemarije L. ;
Stallberg, Bjorn ;
Jones, Rupert C. M. ;
Tsiligianni, Ioanna G. ;
Lisspers, Karin ;
van der Molen, Thys ;
Kocks, Jan Willem H. ;
Chavannes, Niels H. .
PLOS ONE, 2014, 9 (03)
[9]  
Lakemedelsverket Medical Products Agency (Sweden), 2015, LAKEMEDELVERKETS EXP
[10]   Determinants of Underdiagnosis of COPD in National and International Surveys [J].
Lamprecht, Bernd ;
Soriano, Joan B. ;
Studnicka, Michael ;
Kaiser, Bernhard ;
Vanfleteren, Lowie E. ;
Gnatiuc, Louisa ;
Burney, Peter ;
Miravitlles, Marc ;
Garcia-Rio, Francisco ;
Akbari, Kaveh ;
Ancochea, Julio ;
Menezes, Ana M. ;
Perez-Padilla, Rogelio ;
Montes de Oca, Maria ;
Torres-Duque, Carlos A. ;
Caballero, Andres ;
Gonzalez-Garcia, Mauricio ;
Buist, Sonia .
CHEST, 2015, 148 (04) :971-985